These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15380020)
21. BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line. Kohno R; Sawada H; Kawamoto Y; Uemura K; Shibasaki H; Shimohama S Biochem Biophys Res Commun; 2004 May; 318(1):113-8. PubMed ID: 15110760 [TBL] [Abstract][Full Text] [Related]
22. Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: a link to autonomic dysfunction in Parkinson's disease. Marrachelli VG; Miranda FJ; Alabadí JA; Milán M; Cano-Jaimez M; Kirstein M; Alborch E; Fariñas I; Pérez-Sánchez F Neurochem Int; 2010 Jul; 56(8):991-8. PubMed ID: 20420875 [TBL] [Abstract][Full Text] [Related]
24. The role of alpha-synuclein in Parkinson's disease: insights from animal models. Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K Nat Rev Neurosci; 2003 Sep; 4(9):727-38. PubMed ID: 12951565 [No Abstract] [Full Text] [Related]
25. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Totterdell S; Hanger D; Meredith GE Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420 [TBL] [Abstract][Full Text] [Related]
26. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein. Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098 [TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein mRNA expression in sporadic Parkinson's disease. Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423 [TBL] [Abstract][Full Text] [Related]
28. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease. Kim S; Seo JH; Suh YH Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987 [TBL] [Abstract][Full Text] [Related]
30. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265 [TBL] [Abstract][Full Text] [Related]
31. Gene dosage and pathogenesis of Parkinson's disease. Eriksen JL; Przedborski S; Petrucelli L Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766 [TBL] [Abstract][Full Text] [Related]
32. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. Mirzaei H; Schieler JL; Rochet JC; Regnier F Anal Chem; 2006 Apr; 78(7):2422-31. PubMed ID: 16579629 [TBL] [Abstract][Full Text] [Related]
33. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558 [TBL] [Abstract][Full Text] [Related]
34. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Masliah E; Rockenstein E; Adame A; Alford M; Crews L; Hashimoto M; Seubert P; Lee M; Goldstein J; Chilcote T; Games D; Schenk D Neuron; 2005 Jun; 46(6):857-68. PubMed ID: 15953415 [TBL] [Abstract][Full Text] [Related]
35. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]
36. Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease. Lo Bianco C; Déglon N; Pralong W; Aebischer P Neurobiol Dis; 2004 Nov; 17(2):283-9. PubMed ID: 15474365 [TBL] [Abstract][Full Text] [Related]
37. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Chandra S; Fornai F; Kwon HB; Yazdani U; Atasoy D; Liu X; Hammer RE; Battaglia G; German DC; Castillo PE; Südhof TC Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14966-71. PubMed ID: 15465911 [TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134 [TBL] [Abstract][Full Text] [Related]
39. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Wakamatsu M; Ishii A; Iwata S; Sakagami J; Ukai Y; Ono M; Kanbe D; Muramatsu S; Kobayashi K; Iwatsubo T; Yoshimoto M Neurobiol Aging; 2008 Apr; 29(4):574-85. PubMed ID: 17174013 [TBL] [Abstract][Full Text] [Related]